While these two entities share similarities, such as expression of melanoma markers, CCS lacks BRAF mutations and is characterized by distinct genetic features, including EWSR1–ATF1 or EWSR1–CREB1 gene fusions. This evidence concerns the gene EWSR1 and melanoma.